Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004444240 | SCV004928058 | uncertain significance | Inborn genetic diseases | 2024-02-05 | criteria provided, single submitter | clinical testing | The c.1460C>T (p.T487M) alteration is located in exon 14 (coding exon 14) of the CLCN2 gene. This alteration results from a C to T substitution at nucleotide position 1460, causing the threonine (T) at amino acid position 487 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038669 | SCV005665065 | uncertain significance | Epilepsy, idiopathic generalized, susceptibility to, 11; Familial hyperaldosteronism type II; Leukoencephalopathy with mild cerebellar ataxia and white matter edema | 2024-06-17 | criteria provided, single submitter | clinical testing |